Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Wick

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Antiviral Research|January 1, 1993
Studies on the effect of CL 306,293, a substituted quinoline carboxylic acid, on the clinical disease induced in mice with LP-BM5 virusJ W Scott, S Q DeJoy, R Jeyaseelan, et al.
Cellular Immunology|October 15, 1995
Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: comparison with interleukin-2W Munger, S Q DeJoy, R Jeyaseelan, et al.
The Journal of Biological Chemistry|November 20, 1997
CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferationE E Brooks, N S Gray, A Joly, et al.
Diabetes|April 6, 2001
A novel small molecule that directly sensitizes the insulin receptor in vitro and in vivoV P Manchem, I D Goldfine, R A Kohanski, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Antiviral Research|January 1, 1993
Studies on the effect of CL 306,293, a substituted quinoline carboxylic acid, on the clinical disease induced in mice with LP-BM5 virusJ W Scott, S Q DeJoy, R Jeyaseelan, et al.
Cellular Immunology|October 15, 1995
Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: comparison with interleukin-2W Munger, S Q DeJoy, R Jeyaseelan, et al.
The Journal of Biological Chemistry|November 20, 1997
CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferationE E Brooks, N S Gray, A Joly, et al.
Diabetes|April 6, 2001
A novel small molecule that directly sensitizes the insulin receptor in vitro and in vivoV P Manchem, I D Goldfine, R A Kohanski, et al.
Pageof 7